TMCI
Treace Medical Concepts, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$4.81
−1.43%Year over year
Reported trailing growth
- Revenue
- -4.0%
- EBITDA
- -31.2%
- EBIT
- -12.2%
- EPS
- -18.0%
- Free cash flow
- +14.1%
- Operating cash flow
- +2.1%
Forward estimates
Based on analyst estimates
- Revenue
- +5.0%
- EBITDA
- +16.7%
- EPS
- +14.1%
Three-year CAGR
- Revenue
- +14.5%
- EBITDA
- -2.6%
- EBIT
- +2.8%
- Net income
- -5.8%
- EPS
- -3.3%
- Free cash flow
- +39.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026